www.fdanews.com/articles/125436-teva-to-acquire-ratiopharm-in-deal-valued-near-5-billion

Teva to Acquire Ratiopharm in Deal Valued Near $5 Billion

March 18, 2010

Teva Pharmaceutical Industries Ltd. won the bidding for generic-drug manufacturer Ratiopharm, agreeing to buy the German firm in a deal valued at 3.63 billion euros ($4.97 billion).
MarketWatch